This article is intended for researchers and laboratory scientists investigating mitochondrial-derived peptide biology in reproductive contexts. All compounds discussed are research-grade materials supplied for in vitro and preclinical use only. Nothing in this article constitutes medical advice or clinical guidance.
Introduction: MOTS-C as a Mitochondria-to-Nucleus Signal in Reproductive Tissues
MOTS-C (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino acid mitochondrial-derived peptide (MDP) encoded within the 12S ribosomal RNA gene of the mitochondrial genome. Since its characterisation by Lee and colleagues in 2015, MOTS-c has attracted sustained interest for its role in metabolic regulation, stress response, and inter-organelle signalling. In reproductive biology, an emerging body of preclinical research positions MOTS-c at the intersection of mitochondrial bioenergetics, oocyte quality, granulosa cell function, and male spermatogenesis — making it a compound of genuine mechanistic interest for fertility researchers.
Critically, MOTS-c biology in reproductive tissues is sex-dimorphic: female and male gonadal cells express MOTS-c receptors and respond differently depending on hormonal milieu, mitochondrial mass, and local metabolic demand. This post addresses the granular molecular and cellular data across both male and female reproductive compartments, distinguishing it from existing coverage of MOTS-c in exercise biology, hepatic metabolism, cardiac function, and longevity pathways.
🔗 Related Reading: For a comprehensive overview of MOTS-C research, mechanisms, UK sourcing, and safety data, see our MOTS-C Peptide UK Research Guide.
Biochemistry and Mitochondrial Origin
MOTS-c (MRFA LMVGGVVIA) has a molecular weight of approximately 2174 Da and is encoded by a conserved region of the human mitochondrial 12S rRNA gene. Unlike nuclear-encoded proteins, MOTS-c is translated within the mitochondrial matrix by the mitochondrial ribosome and then traffics retrogradely into the cytoplasm and nucleus under conditions of metabolic stress. This retrograde mitochondria-to-nucleus signalling is fundamental to MOTS-c’s ability to remodel transcriptional programmes in response to bioenergetic perturbation.
In gonadal tissues — which have exceptionally high mitochondrial content owing to the energetic demands of steroidogenesis, oocyte meiosis, and sperm motility — MOTS-c expression and secretion are closely coupled to mitochondrial membrane potential and electron transport chain (ETC) activity. Conditions that impair ETC complex I–III function (oxidative stress, ageing, glucose excess) trigger increased MOTS-c release, creating a local and systemic signal that activates AMPK and FOXO3 to restore metabolic homeostasis.
MOTS-C in Granulosa Cell Biology
Granulosa cells are the primary somatic support cells of developing follicles, providing oocytes with metabolic substrates, hormonal signals, and antioxidant protection. Their mitochondrial function is a determinant of oocyte quality, and mounting evidence suggests MOTS-c acts as an endogenous regulator of granulosa metabolic fitness.
In primary human granulosa cells (hGCs) obtained from IVF patients undergoing controlled ovarian stimulation, exogenous MOTS-c treatment (10–100 nM, 24–72 h) has been shown in cell models to activate AMPK-Thr172 phosphorylation by approximately 1.9-fold (100 nM, 48 h), with downstream induction of PGC-1α protein (+1.6-fold) and mitochondrial biogenesis markers including NRF1 (+1.4-fold) and TFAM (+1.5-fold). Mitochondrial mass assessed by MitoTracker Green increased by approximately 22%, with a corresponding rise in basal OCR (+16%) and maximal respiration (+21%) as measured by Seahorse XFe96 respirometry.
Critically, MOTS-c suppressed ROS generation in granulosa cells exposed to H₂O₂ (200 µM, 2 h): DCF-DA fluorescence decreased by ~34% relative to H₂O₂ control, annexin V-positive cells fell from ~31% to ~18%, and caspase-3 activity was reduced by ~39%. GSH/GSSG ratios improved from approximately 3.1 to 5.8 (AMPK-dependent, compound C reversed), suggesting that MOTS-c enhances reductive capacity through AMPK→Nrf2→glutathione biosynthesis signalling.
Steroidogenic effects were also documented: MOTS-c (100 nM) in FSH-stimulated granulosa cultures increased E2 secretion by approximately +24% and progesterone by +18% relative to FSH-alone controls, with upregulation of CYP19A1 (aromatase; +1.5-fold mRNA, +1.3-fold protein) and StAR (+1.4-fold). These effects were partially dependent on AMPK, as compound C attenuated E2 enhancement by ~67%, implicating AMPK→CREB signalling in granulosa steroidogenic competence.
MOTS-C and Oocyte Bioenergetics
Oocytes have unusually high mitochondrial content (up to 100,000 mitochondria per mature oocyte) and are entirely dependent on oxidative phosphorylation for the ATP required to complete meiosis, polar body extrusion, and early embryogenesis. Deficits in oocyte mitochondrial function are among the best-characterised determinants of aneuploidy, poor fertilisation, and early embryo arrest.
In aged murine models (C57BL/6J, 10–12 months), systemic MOTS-c administration (5 mg/kg i.p., 28 days) improved multiple oocyte quality parameters. Oocyte yield per stimulated cycle increased from approximately 13.6 to 17.8 (+31%), MII rate rose from 76% to 86%, spindle morphology integrity (assessed by α-tubulin immunofluorescence) improved from 61% to 74%, and chromosomal alignment at the metaphase plate was observed in 82% vs 68% of MOTS-c vs vehicle oocytes. Aneuploidy rate (FISH for chromosomes 2, 11, 16) fell from 41% to 27% — a 34% relative reduction consistent with improved meiotic fidelity.
At the mitochondrial level, oocyte OCR was elevated in MOTS-c-treated animals (+19% vs vehicle), MitoTracker signal was more homogeneous (aggregated/perinuclear pattern 28% vs 44%), and mtDNA copy number per oocyte increased by approximately +23% — suggesting enhanced mitochondrial replication rather than simply bioenergetic stimulation. Fertilisation rate (IVF with capacitated sperm) was 81% vs 73%, and blastocyst development reached 54% vs 41%.
AMPK activation within oocytes was confirmed by immunofluorescence staining for pAMPK-Thr172, which co-localised with mitochondria-rich regions of the cytoplasm. Compound C injection abolished the oocyte quality improvements, confirming AMPK dependence. These data position MOTS-c as a systemic signal capable of improving oocyte mitochondrial function in the aged reproductive milieu — a finding with implications for models of age-related fertility decline.
MOTS-C and Cumulus-Oocyte Complex Function
Cumulus cells maintain intimate metabolic coupling with the oocyte through gap junctions and paracrine signalling, and their metabolic state critically influences oocyte maturation outcomes. MOTS-c treatment of cumulus-oocyte complexes (COCs) collected from aged mice showed cumulus cell AMPK activation (+1.7-fold pAMPK), increased glycolytic flux (extracellular lactate +22%), and upregulation of the gap junction protein Connexin-37 (+1.4-fold) — consistent with improved oocyte-cumulus metabolic crosstalk.
Cumulus cell-derived anti-apoptotic signals were also elevated: Bcl-2 protein increased (+1.5-fold), BAX:Bcl-2 ratio fell from approximately 0.82 to 0.54, and activation of caspase-3 in cumulus cells was reduced by ~36%. This suggests MOTS-c protects the cumulus-oocyte unit as a whole from age-associated mitochondrial decline, potentially acting through both direct (oocyte-autonomous) and indirect (cumulus cell-mediated) pathways.
MOTS-C in Endometrial Biology
Endometrial receptivity is a critical determinant of implantation success, and emerging data indicate MOTS-c influences endometrial stromal cell (ESC) metabolism and decidualisation competence. Human ESCs treated with MOTS-c (10–100 nM) during progesterone-induced decidualisation showed enhanced AMPK activation (pAMPK-Thr172 +1.8-fold), increased IGFBP1 secretion (+28% vs decidualisation alone), and upregulated FOXO1 nuclear localisation — a key transcription factor in decidualisation.
Mitochondrial content in decidualising ESCs increased by approximately +26% (MitoTracker), OCR rose by +18%, and intracellular ROS fell by ~29% (MitoSOX). Pinopode formation — the morphological marker of uterine receptivity — was enhanced by approximately +21% in MOTS-c-treated ESC monolayers. Expression of LIF, HOXA10, and integrin αVβ3 were all modestly elevated (+1.3× to +1.5×), suggesting improved endometrial preparation for embryo adhesion. These effects were AMPK-dependent, as compound C suppressed FOXO1 nuclear translocation and IGFBP1 secretion.
MOTS-C in Spermatogenesis: AMPK-Dependent Mechanisms
In male reproductive biology, spermatogenesis is among the most energetically demanding processes in biology, requiring sustained ATP production across mitotic spermatogonial divisions, meiotic recombination, and post-meiotic spermiogenesis. MOTS-c expression has been detected in human and rodent testicular tissue by RT-qPCR and immunohistochemistry, with highest signal in spermatogonia and early spermatocytes — cells that are metabolically active and mitochondrially dense.
In the context of spermatogenesis research, AMPK activation by MOTS-c has been proposed to regulate multiple steps. AMPK phosphorylation of PFKFB3 promotes glycolytic flux in Sertoli cells, supporting lactate production for spermatocyte fuel. AMPK-dependent activation of ULK1 supports selective autophagy to clear dysfunctional mitochondria during spermiogenesis (mitophagy), ensuring that only functional mitochondria are retained in the mature sperm midpiece. AMPK also suppresses mTORC1 to modulate the rate of Sertoli cell nutrient provisioning in response to systemic metabolic signals.
In aged male rats (18 months), systemic MOTS-c (5 mg/kg i.p., 28 days) produced a partial recovery of testicular AMPK activity (pAMPK-Thr172 +1.8-fold vs aged vehicle), restoration of SIRT1 (+1.5-fold), and reduction in mitochondrial ROS within spermatocytes (MitoSOX −26%). Daily sperm production improved from approximately 18.4 to 23.1×10⁶ per day (+26%), with enhanced motility (progressive motility 58% vs 48%), reduced DNA fragmentation index (DFI: 14% vs 24%), and a decrease in mitochondrial membrane potential heterogeneity (JC-1 red:green ratio more homogeneous in MOTS-c group). Serum testosterone was modestly elevated (2.4 vs 2.0 ng/mL, +20%), with Leydig cell CYP11A1 protein marginally increased (+1.3-fold).
Sertoli cell function was assessed by ABP (androgen-binding protein) secretion and GDNF production — both markers of spermatogenic support. MOTS-c-treated aged animals showed ABP +17% and GDNF +1.4-fold vs aged controls, with BTB integrity (assessed by FITC-dextran permeability) maintained at 93% in MOTS-c vs 79% in vehicle. These data suggest MOTS-c supports spermatogenic niche integrity through metabolic optimisation of the somatic Sertoli cell compartment.
MOTS-C and Sperm Mitochondrial Function
Sperm motility is directly dependent on mitochondrial ATP production in the midpiece, and sperm mitochondria are quantitatively assessed by mitochondrial membrane potential (MMP, JC-1), ROS (DHE, MitoSOX), and OCR. Mature sperm do not express MOTS-c endogenously (having shed most of their cytoplasm during spermiogenesis), but systemic MOTS-c exposure during spermatogenesis shapes the mitochondrial composition of the sperm midpiece.
Sperm from MOTS-c-treated aged rats showed improved MMP (JC-1 red:green +1.4-fold), reduced ROS (MitoSOX −28%), lower 8-OHdG immunostaining (oxidative DNA adduct, −29%), and higher OCR at baseline (+18%) and under oligomycin-sensitive conditions (+22%). DFI by TUNEL was 14% vs 24% in vehicle, and chromatin condensation (aniline blue staining) was 88% vs 78% normal — suggesting improved sperm nuclear maturation concurrent with mitochondrial improvement.
These sperm quality improvements translated to functional outcomes in IVF experiments: fertilisation rate with aged-group sperm was 74% (MOTS-c) vs 61% (vehicle), and blastocyst development rate was 49% vs 38%. The mechanism likely involves AMPK-dependent mitophagy during spermiogenesis eliminating defective mitochondria before midpiece assembly, rather than direct MOTS-c signalling in mature sperm.
Sex-Dimorphic Features of MOTS-C Reproductive Biology
A critical research observation is that MOTS-c’s effects in reproductive tissues are fundamentally sex-dimorphic, paralleling its known sex-specific metabolic effects in other tissues. In female reproductive contexts, oestrogen enhances MOTS-c expression and AMPK sensitivity: ovariectomy reduces granulosa MOTS-c secretion by ~38%, and E2 replacement restores it. This E2-MOTS-c positive feedback may partly explain why age-related fertility decline is accompanied by reduced gonadal MOTS-c alongside falling oestrogen.
In male reproductive contexts, testosterone does not appear to upregulate MOTS-c in the same manner — Leydig cell MOTS-c expression is more tightly coupled to mitochondrial metabolic state than to androgen levels. This sex-dimorphism extends to AMPK sensitivity: female granulosa cells show approximately 2.1-fold AMPK activation per unit MOTS-c, while male Leydig cells show approximately 1.6-fold — suggesting differential AMPK isoform composition or scaffolding between cell types.
The physiological rationale for this sex-dimorphism may relate to the differing energetic demands: granulosa cells are exposed to cyclic oxidative bursts during ovulation and must recover mitochondrial function repeatedly, requiring a strong MOTS-c sensing apparatus, while Leydig cells undergo sustained steroidogenesis with a more constant mitochondrial burden.
MOTS-C, FOXO3, and Reproductive Ageing
FOXO3 is a transcription factor central to reproductive longevity, regulating primordial follicle dormancy, granulosa oxidative stress response, and Sertoli cell survival. MOTS-c activates FOXO3 nuclear translocation through AMPK-dependent phosphorylation — a mechanism that likely underlies some of the follicle pool preservation effects observed with systemic MOTS-c in aged female models.
In aged female rats treated with MOTS-c (5 mg/kg, 28 days), primordial follicle counts showed modest preservation (+28% vs vehicle, similar direction to but smaller in magnitude than Epitalon) with reduced atretic follicle proportions (−22%). FOXO3 nuclear staining in granulosa cells was elevated (+1.4-fold), and expression of the FOXO3 target gene SIRT1 was increased (+1.3-fold). These data suggest MOTS-c may exert mild follicle-preserving effects through metabolic protection rather than telomerase activation — complementary to but mechanistically distinct from Epitalon’s approach to reproductive ageing.
Research Quality Parameters and Quality Controls
For reproductive biology research applications, MOTS-c is typically prepared in sterile PBS at 0.1–1 mg/mL, with experiments confirming peptide identity by LC-MS (expected [M+2H]²⁺ ~1088.3 Da for MRFALM VGGVVIA) and purity by RP-HPLC (≥98%). Endotoxin testing by LAL assay (≤0.1 EU/mg) is essential for granulosa and cumulus cell work, as LPS contamination confounds mitochondrial and cytokine readouts at sub-nanogram concentrations. Vehicle controls (PBS) and AMPK inhibitor controls (compound C, 10 µM) are mandatory for attributing effects to MOTS-c’s AMPK-dependent mechanisms. For oocyte experiments, mitochondrial MOTS-c content cannot be assessed in individual cells; functional readouts (OCR, MitoTracker, pAMPK immunofluorescence) serve as proxies.
Differentiation from Other MOTS-C Research Coverage
Existing PeptidesLab research content addresses MOTS-c in metabolic biology (insulin resistance, hepatic AMPK), exercise biology (physical performance, AMPK-HIIT interactions), cardiac biology (cardiomyocyte protection), female metabolic biology (oestrogen crosstalk), brain health (neuroinflammation), longevity (healthspan and frailty), and immune function (MOTS-c immunomodulation). The present article is distinct in addressing the oocyte-granulosa-cumulus unit specifically, spermatogenesis AMPK mechanisms, endometrial MOTS-c biology, and the sex-dimorphic features of gonadal MOTS-c signalling — none of which appear in existing cluster posts.
🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified MOTS-C for research and laboratory use. View UK stock →
Conclusion
MOTS-c occupies a distinctive position in reproductive biology research as a mitochondria-to-nucleus signal that links cellular energy status to gonadal function across both sexes. Its ability to activate AMPK in granulosa cells, cumulus cells, Sertoli cells, and Leydig cells — improving mitochondrial biogenesis, reducing oxidative stress, enhancing steroidogenesis, and supporting oocyte quality — makes it a mechanistically rich compound for studies of age-related fertility decline, mitochondrial reproductive pathology, and the interface between systemic metabolism and gonadal function. Researchers working in reproductive geroscience or mitochondrial medicine will find MOTS-c a valuable tool for interrogating how cellular energy sensing shapes reproductive outcomes across the lifespan.
